Douglas Melamed

Doug Melamed is Professor of the Practice of Law at Stanford Law School.  He joined the Stanford faculty in 2014.  In the Fall of 2017, he was the Florence Rogatz Visiting Professor in the Practice of Law at Yale Law School.

From 2009 until 2014, Doug was Senior Vice President and General Counsel of Intel Corporation and was responsible for overseeing Intel’s legal, government affairs, and corporate affairs departments. Prior to joining Intel in 2009, he was a partner in the Washington, D.C., office of WilmerHale, a global law firm in which he served as a chair of the Antitrust and Competition Practice Group.  From 1996 to 2001, he served in the U.S. Department of Justice as Acting Assistant Attorney General in charge of the Antitrust Division and, before that, as Principal Deputy Assistant Attorney General.

Doug has authored numerous articles on antitrust, patent law, and law and economics. He is a member of the American Law Institute and a Contributing Editor of the Antitrust Law Journal and a former member of the boards of directors of the Nasdaq exchanges.  Doug received his B.A. from Yale and his J.D. from Harvard, where he was an editor of the Harvard Law Review.

The United States Needs a National Standards Strategy

By Richard Taffet and Chris Borges Competition among nations for technological and economic leadership is intense, especially between the United States and the People’s Republic of China (PRC). The PRC has followed a decades-long, targeted strategy focused on leadership in critical and emerging technologies (CETs), and, according to some, it has
Read More

How Most-Favored Nation Policy Could Undermine U.S. Leadership

By Dr. Anne Pritchett The United States is the global leader in biopharmaceutical innovation. This leadership is built on the pillars of strong intellectual property protection, substantial investment in research and development (R&D), and a robust innovation ecosystem. These factors, combined with a market-based system that supports competitive drug pricing, encourage innovation and
Read More

U.S. Patenting Abroad — A Quiet Trade Advantage

By Chris Borges   Although patents are territorial, meaning they are limited to the jurisdiction in which they are granted, the networks spanning innovation and commerce are global. U.S. inventors routinely seek patent protection in markets abroad to safeguard their innovations, facilitate exports, and access new customers. By requiring member states
Read More